BioSpace News Archive

IBM Watson Health (NYSE: IBM) and EBSCO Information Services (EBSCO) today announced a strategic collaboration aimed towards enhancing clinical decision support (CDS) and operations for healthcare providers and health systems

Biocare Medical (“Biocare”), a leading developer of world class immunohistochemistry (“IHC”) and molecular reagents and instrumentation, is pleased to announce that Luis de Luzuriaga has joined the company as Chief Executive Officer.

Strand Therapeutics, an mRNA gene therapy company specialized in utilizing synthetic biology for immunotherapy of cancer, announced today the appointment of industry leaders, Dr. Dane Wittrup to its Scientific Advisory Board and Dr. Mark Frohlich to its newly formed Clinical Advisory Board.

Creative Medical Technology Holdings announced today, what appears to be, the first personalized adoptive immunotherapy for treatment of autoimmunity, which the Company named “IMMCELZ™"

ForteBio announced that to aid in the discovery of human therapeutic antibodies to viral infections like dengue fever and eastern equine encephalitis, the Vanderbilt Vaccine Center recently became one of the first academic institutes in North America to adopt ForteBio’s Octet HTX system.

Concord Medical Services Holdings Limited announced that CITIC Industrial Investment Group Limited, a renowned investment institution, will make an investment in Concord Medical’s subsidiary, Meizhong Jiahe Hospital Management Group Co., Ltd., subject to the satisfaction of closing conditions pursuant to an agreement entered into between the parties.

The Exclusive Research Report on “Acral Lentiginous Melanoma Drugs Market with Industry-Primary Research, Secondary Research, Product Research, Revenue, Emerging Trends and Top Growing Companies 2020-2029”.

The Exclusive Research Report on “Acute Lymphocytic/Lymphoblastic Leukemia Treatment Market with Industry-Primary Research, Secondary Research, Product Research, Revenue, Emerging Trends and Top Growing Companies 2020-2029”.

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it has executed a definitive agreement to acquire DeepHealth, Inc. (“DeepHealth”), a leading radiology artificial intelligence (“AI”) and machine learning company initially focused on solutions for the medical interpretation of mammography exams.

Kaiser Permanente is contributing $1 million to 10 leading public health organizations and collaborating with CDC Foundation to strengthen the United States’ public health infrastructure and response systems to stop the spread of COVID-19, the disease caused by the novel coronavirus.